NYSE: ASAN
Asana, Inc.CIK 0001477720 · SIC 7372 · Prepackaged Software
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade ASAN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Asana revenue up 9.9% to $216.4M, net loss narrows 19% to -$39.2M
3 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Asana's Chief Accounting Officer Veronica Sosa resigns, effective August 7
2 material changes detected. Sign up free to read the summary.
Summary not yet generated.
revenue $205.1M, net income -$14.4M. Asana narrows loss 65%, launches AI agent product, acquires StackAI amid CEO transition
5 material changes detected. Sign up free to read the summary.
Asana reports Q1 FY2027 earnings for quarter ended April 30, 2026
1 material change detected. Sign up free to read the summary.
Asana board to shrink 30% as three directors resign in planned refreshment
3 material changes detected. Sign up free to read the summary.
Asana increases executive severance, adopts new bonus plan, promotes CAO
3 material changes detected. Sign up free to read the summary.
revenue $790.8M, net income -$189.0M. Asana narrows loss 26%, boosts buybacks 69%, launches AI products on consumption pricing
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Sep 3, 2026 (period ending Jul 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share amounts)
| Description | Three months ended July 31, 2026 | Three months ended July 31, 2025 | Six months ended July 31, 2026 | Six months ended July 31, 2025 |
|---|---|---|---|---|
| Revenues | 216,429 | 196,936 | 421,524 | 384,203 |
| Cost of revenues | 30,325 | 20,221 | 55,739 | 39,448 |
| Gross profit | 186,104 | 176,715 | 365,785 | 344,755 |
| Operating expenses: | ||||
| Research and development | 81,728 | 79,376 | 147,817 | 154,503 |
| Sales and marketing | 104,384 | 106,677 | 196,848 | 206,518 |
| General and administrative | 41,211 | 40,118 | 77,579 | 77,094 |
| Total operating expenses | 227,323 | 226,171 | 422,244 | 438,115 |
| Loss from operations | (41,219) | (49,456) | (56,459) | (93,360) |
| Interest income and other income (expense), net | 1,918 | 3,307 | 4,821 | 9,137 |
| Interest expense | (645) | (797) | (1,294) | (1,588) |
| Loss before income taxes | (39,946) | (46,946) | (52,932) | (85,811) |
| (Benefit) provision for income taxes | (757) | 1,414 | 662 | 2,567 |
| Net loss | (39,189) | (48,360) | (53,594) | (88,378) |
| Net loss per share: | ||||
| Basic and diluted | (0.17) | (0.20) | (0.23) | (0.38) |
| Weighted-average shares used in calculating net loss per share: | ||||
| Basic and diluted | 230,818 | 236,218 | 234,431 | 235,550 |
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands)
| Description | July 31, 2026 | January 31, 2026 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | 219,562 | 199,835 |
| Marketable securities | 120,289 | 234,210 |
| Restricted cash | 844 | 418 |
| Accounts receivable, net | 78,645 | 110,312 |
| Prepaid expenses and other current assets | 52,428 | 48,573 |
| Total current assets | 471,768 | 593,348 |
| Property and equipment, net | 90,957 | 88,313 |
| Operating lease right-of-use assets | 148,758 | 133,422 |
| Intangible assets | 17,664 | — |
| Goodwill | 56,645 | — |
| Other assets | 30,357 | 29,005 |
| Total assets | 816,149 | 844,088 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | 15,438 | 18,822 |
| Accrued expenses and other current liabilities | 119,875 | 123,716 |
| Deferred revenue, current | 350,337 | 333,636 |
| Operating lease liabilities, current | 27,217 | 24,846 |
| Total current liabilities | 512,867 | 501,020 |
| Deferred revenue, noncurrent | 379 | 220 |
| Operating lease liabilities, noncurrent | 194,050 | 183,749 |
| Other liabilities | 4,530 | 4,982 |
| Total liabilities | 711,826 | 689,971 |
| Commitments and contingencies (Note 9) | ||
| Stockholders' equity | ||
| Common stock | 2 | 2 |
| Additional paid-in capital | 2,403,456 | 2,299,616 |
| Accumulated other comprehensive income | 691 | 4,205 |
| Accumulated deficit | (2,299,826) | (2,149,706) |
| Total stockholders’ equity | 104,323 | 154,117 |
| Total liabilities and stockholders’ equity | 816,149 | 844,088 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Six months ended July 31, 2026 | Six months ended July 31, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | (53,594) | (88,378) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Allowance for expected credit losses | 1,291 | 1,193 |
| Depreciation and amortization | 12,678 | 10,109 |
| Amortization of deferred contract acquisition costs | 13,911 | 13,769 |
| Stock-based compensation expense | 92,648 | 110,321 |
| Net accretion of discount on marketable securities | (362) | (1,278) |
| Non-cash lease expense | 9,930 | 9,122 |
| Amortization of discount on revolving credit facility and term loan issuance costs | 60 | 60 |
| Changes in operating assets and liabilities, net of effects of business combinations: | ||
| Accounts receivable | 30,903 | 17,767 |
| Prepaid expenses and other current assets | (17,086) | (20,179) |
| Other assets | (1,452) | 274 |
| Accounts payable | (3,506) | 6,261 |
| Accrued expenses and other liabilities | (2,400) | (12,170) |
| Deferred revenue | 15,789 | 10,820 |
| Operating lease liabilities | (12,520) | (11,092) |
| Net cash provided by operating activities | 86,290 | 46,599 |
| Cash flows from investing activities | ||
| Cash paid for acquisition, net of acquired cash | (71,616) | — |
| Purchases of marketable securities | (81,750) | (104,096) |
| Sales of marketable securities | 133,603 | — |
| Maturities of marketable securities | 61,021 | 96,576 |
| Purchases of property and equipment | (4,302) | (1,935) |
| Capitalized internal-use software costs | (7,626) | (5,287) |
| Net cash provided by (used in) investing activities | 29,330 | (14,742) |
| Cash flows from financing activities | ||
| Repayment of term loan | (3,750) | (2,500) |
| Repurchases of common stock | (96,526) | (43,398) |
| Proceeds from exercise of stock options | 1,340 | 2,073 |
| Proceeds from employee stock purchase plan | 4,874 | 7,746 |
| Net cash used in financing activities | (94,062) | (36,079) |
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | (1,405) | 4,030 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 20,153 | (192) |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 200,253 | 184,864 |
| End of period | 220,406 | 184,672 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗